Home > Financial Ratios > GLENMARK PHARMACEUTICALS

GLENMARK PHARMACEUTICALS
Core EBITDA Growth

    Back to All Ratios
GLENMARK PHARMACEUTICALS is part of below Screeners ↓
Best 1M Momentum Mid Cap Stocks
COMMUNITY POLL
for GLENMARK PHARMACEUTICALS
Please provide your vote to see the results

GLENMARK PHARMACEUTICALS Last 5 Year Core EBITDA Growth History

[Consolidated]

Mar2025Mar2024Mar2023Mar2022Mar2021
   Core EBITDA Growth(%) 21.125.79-22.6416.5114.91

What is the latest Core EBITDA Growth ratio of GLENMARK PHARMACEUTICALS ?

The latest Core EBITDA Growth ratio of GLENMARK PHARMACEUTICALS is 21.12 based on Mar2025 Consolidated results.
Year Core EBITDA Growth
Mar202521.12
Mar20245.79
Mar2023-22.64
Mar202216.51
Mar202114.91

How is Core EBITDA Growth of GLENMARK PHARMACEUTICALS Trending?

Years Core EBITDA Growth % Change
Mar2025 21.12
264.77
Mar2024 5.79
Positive
Mar2023 -22.64
Negative
Mar2022 16.51
10.73
Mar2021 14.91 -

Other Financial Ratios of GLENMARK PHARMACEUTICALS


Compare Core EBITDA Growth ratio of peers of GLENMARK PHARMACEUTICALS

Peers & Returns Market Capitalization 1 Week 1 Month 1 Year
GLENMARK PHARMACEUTICALS ₹67,433.1 Cr 2.8% 7% 64.3% Stock Analytics
SUN PHARMACEUTICAL INDUSTRIES ₹453,750.0 Cr 0.6% 13.6% 8.4% Stock Analytics
DIVIS LABORATORIES ₹182,117.0 Cr 1.5% 9.1% 9.7% Stock Analytics
TORRENT PHARMACEUTICALS ₹151,314.0 Cr 1.5% 8.2% 35.7% Stock Analytics
CIPLA ₹113,225.0 Cr -2.1% 13.7% -6.7% Stock Analytics
DR REDDYS LABORATORIES ₹110,037.0 Cr -1.4% 8% 7.4% Stock Analytics


GLENMARK PHARMACEUTICALS Share Price vs Sensex


Share Price Returns(%) 1 Week 1 Month 1 Year
GLENMARK PHARMACEUTICALS

2.8%

7%

64.3%

SENSEX

-0.3%

-4.3%

-8.9%


You may also like the below Video Courses